Suppr超能文献

基于分子对接的柯里拉京 A-4 类似物的 3D-QSAR 研究

3D-QSAR Study of Combretastatin A-4 Analogs Based on Molecular Docking.

作者信息

Jin Yinghua, Qi Ping, Wang Zhiwei, Shen Qirong, Wang Jian, Zhang Weige, Song Hongrui

机构信息

Department of Pharmacy, General Hospital of Beijing Military Command. Nanmencang No.5, Dongcheng District, Beijing 100700, China.

School of Pharmaceutical Engineering, Shenyang Pharmaceutical University. No.103, Wenhua Road, Shenhe District, Shenyang 110016, Liaoning, China.

出版信息

Molecules. 2011 Aug 8;16(8):6684-700. doi: 10.3390/molecules16086684.

Abstract

Combretastatin A-4 (CA-4), its analogues and their excellent antitumoral and antivascular activities, have attracted considerable interest of medicinal chemists. In this article, a docking simulation was used to identify molecules having the same binding mode as the lead compound, and 3D-QSAR models had been built by using CoMFA based on docking. As a result, these studies indicated that the QSAR models were statistically significant with high predictabilities (CoMFA model, q2 = 0.786, r2 = 0.988). Our models may offer help to better comprehend the structure-activity relationships for this class of compounds and also facilitate the design of novel inhibitors with good chemical diversity.

摘要

康普瑞他汀A-4(CA-4)及其类似物具有出色的抗肿瘤和抗血管活性,已引起药物化学家的广泛关注。在本文中,通过对接模拟来识别与先导化合物具有相同结合模式的分子,并基于对接结果利用比较分子场分析法(CoMFA)构建了三维定量构效关系(3D-QSAR)模型。结果表明,这些研究中的QSAR模型具有统计学意义且预测能力较高(CoMFA模型,交叉验证系数q2 = 0.786,相关系数r2 = 0.988)。我们的模型可能有助于更好地理解这类化合物的构效关系,也有助于设计具有良好化学多样性的新型抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f208/6264539/04d739150605/molecules-16-06684-g001.jpg

相似文献

1
3D-QSAR Study of Combretastatin A-4 Analogs Based on Molecular Docking.
Molecules. 2011 Aug 8;16(8):6684-700. doi: 10.3390/molecules16086684.
2
Binding conformations and QSAR of CA-4 analogs as tubulin inhibitors.
J Enzyme Inhib Med Chem. 2010 Jun;25(3):421-9. doi: 10.3109/14756360903213499.
5
Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
Curr Comput Aided Drug Des. 2016;12(4):302-313. doi: 10.2174/1573409912666160901112720.
8
3D-QSAR study of c-Src kinase inhibitors based on docking.
J Mol Model. 2010 Feb;16(2):361-75. doi: 10.1007/s00894-009-0530-1. Epub 2009 Jul 17.
9
Synthesis, biological evaluation and 3D-QSAR studies of novel 5-phenyl-1H-pyrazol cinnamamide derivatives as novel antitubulin agents.
Eur J Med Chem. 2015 Mar 26;93:291-9. doi: 10.1016/j.ejmech.2015.02.018. Epub 2015 Feb 14.
10
Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4.
Bioorg Med Chem. 2013 Mar 1;21(5):1357-66. doi: 10.1016/j.bmc.2012.11.056. Epub 2012 Dec 21.

引用本文的文献

1
New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization.
Mol Divers. 2024 Apr;28(2):563-580. doi: 10.1007/s11030-023-10603-z. Epub 2023 Feb 15.
3
Design, synthesis and molecular docking of novel diarylcyclohexenone and diarylindazole derivatives as tubulin polymerization inhibitors.
J Enzyme Inhib Med Chem. 2017 Dec;32(1):176-188. doi: 10.1080/14756366.2016.1244532. Epub 2016 Oct 24.
4
Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.
Org Biomol Chem. 2016 Jan 7;14(1):40-9. doi: 10.1039/c5ob02005k. Epub 2015 Oct 27.
5
Far-red light activatable, multifunctional prodrug for fluorescence optical imaging and combinational treatment.
J Med Chem. 2014 Apr 24;57(8):3401-9. doi: 10.1021/jm5000722. Epub 2014 Apr 14.
6
Combined structure-based pharmacophore and 3D-QSAR studies on phenylalanine series compounds as TPH1 inhibitors.
Int J Mol Sci. 2012;13(5):5348-5363. doi: 10.3390/ijms13055348. Epub 2012 May 2.

本文引用的文献

1
Molecular dynamics simulations of 2-amino-6-arylsulphonylbenzonitriles analogues as HIV inhibitors: interaction modes and binding free energies.
Chem Biol Drug Des. 2010 Dec;76(6):518-26. doi: 10.1111/j.1747-0285.2010.01028.x. Epub 2010 Oct 13.
2
CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
Eur J Med Chem. 2010 Aug;45(8):3413-9. doi: 10.1016/j.ejmech.2010.04.030. Epub 2010 May 21.
3
Binding conformations and QSAR of CA-4 analogs as tubulin inhibitors.
J Enzyme Inhib Med Chem. 2010 Jun;25(3):421-9. doi: 10.3109/14756360903213499.
4
Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors.
Eur J Med Chem. 2009 Sep;44(9):3524-32. doi: 10.1016/j.ejmech.2009.03.028. Epub 2009 Mar 28.
5
Receptor- and ligand-based 3D-QSAR study for a series of non-nucleoside HIV-1 reverse transcriptase inhibitors.
Bioorg Med Chem. 2009 Mar 15;17(6):2400-9. doi: 10.1016/j.bmc.2009.02.003. Epub 2009 Feb 8.
7
Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity.
J Med Chem. 2008 Oct 9;51(19):6211-5. doi: 10.1021/jm8005004. Epub 2008 Sep 11.
8
Synthesis and antitumor activity of benzils related to combretastatin A-4.
Bioorg Med Chem Lett. 2008 Jun 1;18(11):3266-71. doi: 10.1016/j.bmcl.2008.04.053. Epub 2008 Apr 25.
9
Synthesis and biological activity of fluorinated combretastatin analogues.
J Med Chem. 2008 May 8;51(9):2708-21. doi: 10.1021/jm701362m. Epub 2008 Apr 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验